Tracking a UC Treatment's Real-World impact in japan

NCT ID NCT07136116

Summary

This study is observing how well the approved drug risankizumab works for adults with moderate to severe ulcerative colitis in real-world medical settings in Japan. It will follow about 200 patients for up to 3 years as they receive the drug as part of their normal care. The main goal is to see how many patients achieve a state of low disease activity with minimal symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aichi Medical University Hospital /ID# 278155

    RECRUITING

    Nagakute, Aichi-ken, 480-1195, Japan

  • Chiba University Hospital /ID# 277669

    RECRUITING

    Chiba, Chiba, 260-8677, Japan

  • Dokkyo Medical University Hospital /ID# 278152

    RECRUITING

    Mibu, Tochigi, 321-0293, Japan

  • Fukuoka University Hospital /ID# 277677

    RECRUITING

    Fukuoka, 814-0180, Japan

  • Hamamatsu University Hospital /ID# 277539

    RECRUITING

    Hamamatsu, Shizuoka, 431-3192, Japan

  • Hirosaki University Hospital /ID# 278153

    RECRUITING

    Hirosaki, Aomori, 036-8563, Japan

  • Hokkaido University Hospital /ID# 277668

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Hyogo Medical University Hospital /ID# 277676

    RECRUITING

    Nishinomiya-shi, Hyōgo, 663-8501, Japan

  • Institute of Science Tokyo Hospital /ID# 277538

    RECRUITING

    Bunkyo-ku, Tokyo, 113-8519, Japan

  • Kansai Medical University Hospital /ID# 278619

    RECRUITING

    Hirakata-shi, Osaka, 573-1191, Japan

  • Kitasato University Kitasato Institute Hospital /ID# 278154

    RECRUITING

    Minato-ku, Tokyo, 108-8642, Japan

  • Kobe University Hospital /ID# 278292

    RECRUITING

    Kobe, Hyōgo, 650-0017, Japan

  • Kyorin University Hospital /ID# 277534

    RECRUITING

    Mitaka-shi, Tokyo, 181-8611, Japan

  • Kyushu University Hospital /ID# 278077

    RECRUITING

    Fukuoka, Fukuoka, 812-8582, Japan

  • NHO Shizuoka Medical Center /ID# 278075

    RECRUITING

    Sunto-gun, Shizuoka, 411-8611, Japan

  • Nagoya University Hospital /ID# 278159

    RECRUITING

    Nagoya, Aichi-ken, 466-8560, Japan

  • Saga University Hospital /ID# 278160

    RECRUITING

    Saga, Saga-ken, 849-8501, Japan

  • Saitama Medical Center /ID# 278076

    RECRUITING

    Kawagoe, Saitama, 350-8550, Japan

  • Sapporo Higashi Tokushukai Hospital /ID# 278123

    RECRUITING

    Sapporo, Hokkaido, 065-0033, Japan

  • Sapporo Kosei General Hospital /ID# 278048

    RECRUITING

    Sapporo, 060-0033, Japan

  • Sapporo Medical University Hospital /ID# 277535

    RECRUITING

    Sapporo, Hokkaido, 060-8543, Japan

  • Shiga University of Medical Science Hospital /ID# 277540

    RECRUITING

    Ōtsu, Shiga, 520-2192, Japan

  • The Jikei University Hospital /ID# 278122

    RECRUITING

    Tokyo, 105-8461, Japan

  • Toho University Sakura Medical Center /ID# 277536

    RECRUITING

    Sakura, Chiba, 285-0841, Japan

  • Toyama University Hospital /ID# 277675

    RECRUITING

    Toyama, 930-0194, Japan

  • Tsujinaka Hospital - Kashiwanoha /ID# 277672

    RECRUITING

    Kashiwa-shi, Chiba, 277-0871, Japan

  • University Hospital Kyoto Prefectural University of Medicine /ID# 277541

    RECRUITING

    Kyoto, Kyoto, 602-8566, Japan

Conditions

Explore the condition pages connected to this study.